Beyond Brain Fog: How Hormonal Shifts are Rewriting Our Understanding of Cognitive Health Nearly 60% of women report experiencing cognitive difficulties during perimenopause and menopause, often dismissed as ‘brain fog.’ But a growing body of research reveals these aren’t simply fleeting inconveniences. They represent measurable changes in brain structure and function, prompting a paradigm shift … Read more
Nearly 70% of women experiencing significant weight loss through GLP-1 receptor agonists (GLP-1RAs) report noticeable changes in their genital and perigenital areas, a statistic largely unknown to both patients and many healthcare providers. This isn’t simply an aesthetic concern; it signals a potentially widespread, and currently under-addressed, shift in women’s pelvic health. The term “Ozempic … Read more
The GLP-1 Plateau: Why Weight Loss Drugs May Require a Lifetime Commitment – And What Comes Next Nearly 85% of individuals regain a significant portion of weight lost while on GLP-1 receptor agonists like Ozempic and Wegovy within 18 months of discontinuation, according to emerging research. This isn’t a failure of the drugs themselves, but … Read more
Forget the latest celebrity wellness brand pushing overpriced smoothies. The real heat is… well, in the sauna. What began as a deeply ingrained cultural practice in Finland is now a full-blown trend in the UK, and it’s fascinating to watch how quickly it’s moved from niche health practice to a social phenomenon, particularly amongst younger … Read more